Basic info
Industry
biotechnology research
Sectors
Biotechnology
Genome Editing
Genetic Diseases
Blood Diseases
Rare Diseases
Transfusion-Dependent Beta Thalassemia
Immunogenetics
Health Care
Ocular Medicines
Sickle Cell Disease
Genetics
In Vivo (in body) Editing
Medical
Hematopoietic Stem Cells
Cancer
Engineered Cell Medicines
Date founded
2013
Funding rounds raised
Total raised
$120M
from 15 investors over 15 rounds
E
Editas Medicine raised $120M on August 10, 2015
Investors: Omega Funds, Third Rock Ventures, Khosla Ventures, GV, Flagship Ventures, Viking Global Investors, Polaris Partners, Jennison Associates LLC, Innova Capital and T. Rowe Price
E
Editas Medicine raised $47M on May 27, 2015
Investors: Juno Therapeutics, Inc.
E
Editas Medicine raised $43M on November 25, 2013
Investors: Third Rock Ventures, Flagship Ventures, Partners HealthCare and Polaris Partners